1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Allogeneic Stem Cell Market
2.2. Global Allogeneic Stem Cell Market, By Type, 2023 (US$ Million)
2.3. Global Allogeneic Stem Cell Market, By Cell Source, 2023 (US$ Million)
2.4. Global Allogeneic Stem Cell Market, By Application, 2023 (US$ Million)
2.5. Global Allogeneic Stem Cell Market, By End-User, 2023 (US$ Million)
2.6. Global Allogeneic Stem Cell Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023

3. Allogeneic Stem Cell Market: Competitive Analysis
3.1. Market Positioning of Key Allogeneic Stem Cell Market Vendors
3.2. Strategies Adopted by Allogeneic Stem Cell Market Vendors
3.3. Key Industry Strategies
4. Allogeneic Stem Cell Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Allogeneic Stem Cell Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Unmodified Stem Cell Transplant
5.3.2. T-cell depleted Transplant
5.3.3. Cord Blood Transplant
5.3.4. Donor Lymphocyte Infusion (DLI)

6. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Bone Marrow
6.3.2. Peripheral Blood Stem Cell (PBSC)
6.3.3. Umbilical Cord Blood
6.3.4. Adipose Tissue
6.3.5. Others (Placenta)

7. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Musculoskeletal Disease
7.3.2. Cardiovascular Disease
7.3.3. Autoimmune Disease
7.3.4. Oncology
7.3.5. GvHD
7.3.6. Others (Neuro Disorder and Pulmonary Disease)

8. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Hospital
8.3.2. Ambulatory Surgical Center
8.3.3. Others (Cancer Center and Research Institute)


9. North America Allogeneic Stem Cell Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
9.3. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
9.4. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
9.5. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
9.6.Allogeneic Stem Cell Market: By Region, 2022-2032, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
9.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
9.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
9.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
9.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
9.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
9.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
9.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
9.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
9.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)

10. UK and European Union Allogeneic Stem Cell Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
10.3. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
10.4. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
10.5. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
10.6.Allogeneic Stem Cell Market: By Region, 2022-2032, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
10.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
10.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
10.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
10.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
10.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
10.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
10.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
10.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
10.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
10.6.1.4.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
10.6.1.4.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
10.6.1.4.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
10.6.1.5.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
10.6.1.5.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
10.6.1.5.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
10.6.1.6.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
10.6.1.6.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
10.6.1.6.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)

11. Asia Pacific Allogeneic Stem Cell Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
11.3. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
11.4. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
11.5. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
11.6.Allogeneic Stem Cell Market: By Region, 2022-2032, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
11.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
11.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
11.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
11.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
11.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
11.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
11.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
11.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
11.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
11.6.1.4.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
11.6.1.4.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
11.6.1.4.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
11.6.1.5.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
11.6.1.5.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
11.6.1.5.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
11.6.1.6.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
11.6.1.6.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
11.6.1.6.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)

12. Latin America Allogeneic Stem Cell Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
12.3. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
12.4. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
12.5. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
12.6.Allogeneic Stem Cell Market: By Region, 2022-2032, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
12.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
12.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
12.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
12.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
12.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
12.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
12.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
12.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
12.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)

13. Middle East and Africa Allogeneic Stem Cell Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
13.3. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
13.4. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
13.5. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
13.6.Allogeneic Stem Cell Market: By Region, 2022-2032, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
13.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
13.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
13.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
13.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
13.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
13.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2022-2032, USD (Million)
13.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2022-2032, USD (Million)
13.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2022-2032, USD (Million)
13.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2022-2032, USD (Million)

14. Company Profile
14.1. Fresenius Kabi AG
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Regeneron Pharmaceuticals, Inc.
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Novartis International AG
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Sanofi
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. Mesa Biotech, Inc.
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Mesoblast Limited
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Gamida Cell Ltd.
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Cellectis SA
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Magenta Therapeutics Inc.
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Fate Therapeutics Inc.
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Cynata Therapeutics Limited
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Kiadis Pharma N.V.
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Takeda Pharmaceutical Company Limited
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives
14.14. JCR Pharmaceuticals Co., Ltd.
14.14.1. Company Overview
14.14.2. Financial Performance
14.14.3. Product Portfolio
14.14.4. Strategic Initiatives
14.15. Pluristem Therapeutics Inc.
14.15.1. Company Overview
14.15.2. Financial Performance
14.15.3. Product Portfolio
14.15.4. Strategic Initiatives
14.16. Celularity Inc.
14.16.1. Company Overview
14.16.2. Financial Performance
14.16.3. Product Portfolio
14.16.4. Strategic Initiatives
14.17. Lineage Cell Therapeutics Inc.
14.17.1. Company Overview
14.17.2. Financial Performance
14.17.3. Product Portfolio
14.17.4. Strategic Initiatives
14.18. Nohla Therapeutics Inc.
14.18.1. Company Overview
14.18.2. Financial Performance
14.18.3. Product Portfolio
14.18.4. Strategic Initiatives
14.19. Orchard Therapeutics plc
14.19.1. Company Overview
14.19.2. Financial Performance
14.19.3. Product Portfolio
14.19.4. Strategic Initiatives
14.20. Other Notable Players
14.20.1. Company Overview
14.20.2. Financial Performance
14.20.3. Product Portfolio
14.20.4. Strategic Initiatives